Financial Daily from THE HINDU group of publications
Sunday, May 14, 2006
Financial Daily from THE HINDU group of publications Sunday, May 14, 2006 |
|
|
|
|
|
|
|
Corporate
-
Research & Development LifeCell may commence research in July Our Bureau
Mumbai , May 13 Cord-blood banking firm LifeCell expects to commence clinical research in July, when its exclusive stem-cell transplant centre becomes operational in Chennai, said Mr S. Abhaya Kumar, Vice-Chairman and Chief Executive Officer of Asia Cryo-cell Private Ltd. Having tied-up recently with Saneron CCell, a stem cell research company, Mr Kumar said research would be kicked-off in segments such as stroke and spinal cord injuries in July. The studies would be phase IIa trials, where targeted trials are done on a larger sample size of people with the illness. Regulatory clearances have been received, he said. LifeCell's Chennai stem-cell transplant centre is an estimated Rs 15-crore project, he added.
Second unit
The company also has plans for a second banking facility in Mumbai, scheduled to be operational by end 2007. Mr Kumar told Business Line that the company has been talking with a clutch of hospitals in Mumbai towards jointly opening the centre. The estimated project cost is Rs 5 crore. Meanwhile, LifeCell is also introducing information kiosks across 400 retail outlets in Mumbai and 40 hospitals across India. The company has earmarked Rs 1 crore towards this initiative.
More Stories on : Research & Development | Health
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2006, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|